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Matripase Critical for Epithelial Function
The serum protease matripase plays a critical role in
terminal differentiation of epithelial cells in the epider-
mis; however, matripase is broadly expressed in di-
verse epithelia. To elucidate the role of matripase on
other epithelial tissues, List et al (Am J Pathol 2009,
175: 1453–1463) generated matripase-deficient mice.
The loss of matripase was associated with severe or-
gan dysfunction in multiple tissues. These epithelial
tissues manifested increased permeability, loss of tight
junction function, mislocation of tight junction-associ-
ated proteins, and generalized epithelial demise. Matripase
is therefore required for global homeostasis of diverse epi-
thelial tissues.
Diabetes Weakens Your Bones
Diabetic patients often experience osteopenia, which is
associated with increased risk of bone fractures and
delayed fracture repair. Ablowi et al (Am J Pathol 2009,
175: 1574–1585) used a streptozotocin-induced diabe-
tes model to explore bone regeneration in diabetic mice.
They observed increased levels of inflammatory mole-
cules, including tumor-necrosis factor (TNF)-, during
fracture repair in diabetic mice as compared with healthy
mice. Osteoclast numbers and cartilage degradation
rates were also elevated in these mice in a manner de-
pendent on TNF- and its downstream mediator FOXO1.
Inhibition of the transcription factor FOXO1, which was
elevated in chondrocytes in diabetic mice, reduced
TNF- levels. These results suggest diabetes-enhanced
TNF- may induce FOXO1 activation, which then gives
way to activation of inflammatory and resorptive pro-
cesses leading to delayed healing of diabetic fractures.
Dissecting Out Metastasis
Tumor cell intravasation, the entry of aggressive cells into
the vasculature, is an early step in the complex metastatic
process. To explore the mechanisms governing intravasa-
tion, Conn et al (Am J Pathol 2009, 175: 1638–1652) iso-
lated high and low dissemination variants of a prostate
carcinoma cell line; these variants differed in their ability
to intravasate in both chick embryo and mouse sponta-
neous metastasis models. The cell line more prone to
dissemination also had increased angiogenic potential,
and both angiogenesis and intravasation in these cells
were dependent on vascular endothelial growth factor.
These cells were also more migratory and invasive and
produced more of the serine protease urokinase plasmin-
ogen activator (uPA). By inhibiting uPA activation, inva-
sion, angiogenesis, and intravasation were all blocked.
Thus, uPA activation may be instrumental in the early
stages of metastasis.
SPAK Silencing Promotes B-Cell Lymphoma
Survival
Epigenetic changes, such as DNA hypermethylation,
may promote B-cell transformation by silencing tumor
suppressor genes. Serine/threonine protein kinase 39
(Stk39), which encodes STE20 (sterile 20-like)-related
proline-alanine-rich kinase (SPAK), regulates cellular
stress responses; SPAK expression levels are reduced
during cancer progression. Using TCL1 transgenic mice,
which develop B-cell malignancies, and human B-cell
lymphoma tissue samples, Balatoni et al (Am J Pathol
2009, 175: 1653–1661) report that SPAK expression is
inhibited in B-cell tumors due in part to hypermethylation.
Decreased SPAK expression protected B cells from
caspase-mediated apoptosis induced by double-strand
DNA breaks, which can occur as a result of specific
genotoxic stressors. This SPAK-mediated protection may
therefore be responsible for survival and metastatic pro-
gression in DNA-damaged B cells.
Macrophages Key to Inflammation-Induced
Aberrant Lymphangiogenesis
Lymphatic vessels in the diaphragm are responsible for
draining excess peritoneal fluid. To characterize changes
in lymphatic vessels during peritoneal inflammation, Kim
et al (Am J Pathol 2009, 175: 1733–1745) injected lipo-
polysaccharide (LPS) into mice to induce peritonitis. LPS
induced changes in lymphatic vessel structure and func-
tion that were reversible on discontinuation of LPS-in-
duced inflammation. Macrophage migration to these
sites of lymphangiogenesis contributed to lymphatic
remodeling through secretion of vascular endothelial
growth factor C/D, and both macrophage attachment to
the lymphatic vessels and inflammatory fibrosis resulted
in impaired peritoneal fluid drainage. These data high-
light the key role of macrophages in inflammation-in-
duced lymphangiogenesis and lymphatic vessel dys-
function in the diaphragm.
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Decay Accelerating Factor Protects from
Atherosclerosis
Complement activation plays a regulatory role in athero-
sclerotic lesion development; however, whereas proximal
members of the complement pathway have a protective
role, distal components are atherogenic. Decay acceler-
ating factor (DAF) regulates complement activation at the
C3 level, but its role in atherosclerotic lesion development
remains unclear. Leung et al (Am J Pathol 2009, 175:
1757–1767) hypothesized that DAF plays a protective
role in atherosclerosis. Using a DAF-deficient mouse
model of atherosclerosis, they found that DAF-deficient
animals had increased levels of the distal complement
components C5b-9 in aortic lesions. Lesions in DAF-
deficient mice had accelerated development and in-
creased size and complexity compared with normal an-
imals. DAF, therefore, plays an essential regulatory role in
limiting complement activation on the arterial wall and is
protective against atherosclerosis.
1352 This Month in AJP
AJP October 2009, Vol. 175, No. 4
